Wei Kang

484 total citations
28 papers, 299 citations indexed

About

Wei Kang is a scholar working on Molecular Biology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Wei Kang has authored 28 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Infectious Diseases and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Wei Kang's work include SARS-CoV-2 and COVID-19 Research (4 papers), Antibiotic Resistance in Bacteria (4 papers) and Antimicrobial Peptides and Activities (3 papers). Wei Kang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Antibiotic Resistance in Bacteria (4 papers) and Antimicrobial Peptides and Activities (3 papers). Wei Kang collaborates with scholars based in China, Hong Kong and United Kingdom. Wei Kang's co-authors include Changlin Zhou, Hanhan Liu, Jie Dou, Mengxiao Wang, Lingman Ma, Yanrong Wang, Hui Wang, Vincent Ka Chun Yan, Esther W. Chan and Ian Chi Kei Wong and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Wei Kang

26 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Kang China 11 74 61 45 35 34 28 299
Maya Azrad Israel 11 127 1.7× 19 0.3× 117 2.6× 34 1.0× 73 2.1× 48 422
Julio César García Casallas Colombia 10 82 1.1× 11 0.2× 20 0.4× 24 0.7× 47 1.4× 43 266
Yi-Shan Chen China 12 91 1.2× 107 1.8× 45 1.0× 12 0.3× 102 3.0× 34 584
Wenjing Zou China 12 151 2.0× 40 0.7× 57 1.3× 14 0.4× 60 1.8× 46 460
Ashlee D. Brunaugh United States 12 113 1.5× 14 0.2× 48 1.1× 39 1.1× 26 0.8× 16 420
Vincent P. DeMarco United States 7 63 0.9× 31 0.5× 173 3.8× 36 1.0× 170 5.0× 7 428
Christina Smaczny Germany 12 102 1.4× 15 0.2× 81 1.8× 8 0.2× 101 3.0× 24 506
Carlos Guerra Spain 11 134 1.8× 30 0.5× 117 2.6× 25 0.7× 111 3.3× 28 436
Ilka Steiner Austria 11 73 1.0× 16 0.3× 34 0.8× 10 0.3× 49 1.4× 18 350
Shu Yu China 16 153 2.1× 12 0.2× 93 2.1× 25 0.7× 48 1.4× 27 651

Countries citing papers authored by Wei Kang

Since Specialization
Citations

This map shows the geographic impact of Wei Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Kang more than expected).

Fields of papers citing papers by Wei Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Kang. The network helps show where Wei Kang may publish in the future.

Co-authorship network of co-authors of Wei Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Kang. A scholar is included among the top collaborators of Wei Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Kang. Wei Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jia, Peiyao, Pengcheng Li, Wei Yu, et al.. (2025). Clinical imipenem non-susceptible Klebsiella pneumoniae isolates from China: Epidemiology, molecular characterization and in vitro activity of imipenem/relebactam. Journal of Global Antimicrobial Resistance. 44. 1–7.
3.
Kang, Wei, Vincent Ka Chun Yan, Yue Wei, et al.. (2024). Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis. Nature Communications. 15(1). 5657–5657. 3 indexed citations
4.
Kang, Wei, Vincent Ka Chun Yan, Daoud Al‐Badriyeh, et al.. (2024). Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis. Journal of Pharmaceutical Policy and Practice. 17(1). 2375269–2375269.
5.
Chen, Fangfang, Zhihong Liu, Wei Kang, et al.. (2024). Single-domain antibodies against SARS-CoV-2 RBD from a two-stage phage screening of universal and focused synthetic libraries. BMC Infectious Diseases. 24(1). 199–199. 1 indexed citations
6.
Kang, Wei, et al.. (2024). Research progress on S-palmitoylation modification mediated by the ZDHHC family in glioblastoma. Frontiers in Cell and Developmental Biology. 12. 1413708–1413708. 3 indexed citations
7.
Shen, Zhen, et al.. (2023). Clinical efficacy in one-year treatment with Artemisia annua-SLIT drops in monosensitized and polysensitized individuals. American Journal of Otolaryngology. 44(6). 104002–104002. 4 indexed citations
8.
Morrissey, Ian, Meng Xiao, Tianshu Sun, et al.. (2022). In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in China. Infection and Drug Resistance. Volume 15. 2101–2113. 6 indexed citations
9.
Ye, Xuxiao, Joseph E. Blais, V Ng, et al.. (2022). Association between statins and the risk of suicide attempt, depression, anxiety, and seizure: A population-based, self-controlled case series study. Journal of Affective Disorders. 320. 421–427. 4 indexed citations
10.
Ye, Xuxiao, Tiantian Ma, Joseph E. Blais, et al.. (2022). Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease. Cardiovascular Research. 118(10). 2329–2338. 19 indexed citations
11.
Kang, Wei, Vincent Ka Chun Yan, Xuxiao Ye, et al.. (2022). Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study. Journal of Hematology & Oncology. 15(1). 66–66. 12 indexed citations
12.
Xu, Minjie, Lingli Chen, Zijing Wu, et al.. (2022). The HALP (hemoglobin, albumin, lymphocyte, and platelet) score is associated with early-onset post-stroke cognitive impairment. Neurological Sciences. 44(1). 237–245. 31 indexed citations
13.
Jia, Peiyao, Ying Zhu, Wei Yu, et al.. (2022). Antimicrobial susceptibility to polymyxin B and other comparators against Gram-negative bacteria isolated from bloodstream infections in China: Results from CARVIS-NET program. Frontiers in Microbiology. 13. 1017488–1017488. 13 indexed citations
14.
Wan, Chuan, Wei Kang, Rui Wang, et al.. (2022). A Proximity-Triggered Strategy toward Transferable Proteolysis Targeting Chimeras. CCS Chemistry. 5(6). 1433–1442. 7 indexed citations
15.
Yang, Jiayi, et al.. (2022). Clinical Efficacy and Safety of <b><i>Artesimia annua</i></b>-Sublingual Immunotherapy in Seasonal Allergic Rhinitis Patients Based on Different Intervention Time. International Archives of Allergy and Immunology. 183(8). 852–859. 12 indexed citations
16.
Kang, Wei, Hanhan Liu, Lingman Ma, et al.. (2017). Effective antimicrobial activity of a peptide mutant Cbf-14-2 against penicillin-resistant bacteria based on its unnatural amino acids. European Journal of Pharmaceutical Sciences. 105. 169–177. 22 indexed citations
17.
Kang, Wei, et al.. (2017). A gold nanostar-based SERS platform for point-of-care diagnostics of carbapenemase-producing enterobacteriacae. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 10340. 1034011–1034011. 3 indexed citations
18.
Li, Bo, Wei Kang, Hanhan Liu, et al.. (2016). The antimicrobial activity of Cbf-K16 against MRSA was enhanced by β-lactamantibiotics through cell wall non-integrity. Archives of Pharmacal Research. 39(7). 978–988. 12 indexed citations
19.
Ma, Lingman, Yanrong Wang, Mengxiao Wang, et al.. (2016). Effective antimicrobial activity of Cbf-14, derived from a cathelin-like domain, against penicillin-resistant bacteria. Biomaterials. 87. 32–45. 52 indexed citations
20.
Kang, Wei, Anthony K. H. Tung, Wei Chen, et al.. (2014). Trendspedia: An Internet observatory for analyzing and visualizing the evolving web. 3. 1206–1209. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026